BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 14671675)

  • 1. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
    Cheuk AT; Mufti GJ; Guinn BA
    Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
    DeBenedette MA; Shahinian A; Mak TW; Watts TH
    J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 4-1BB in immune responses.
    Vinay DS; Kwon BS
    Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
    Sica G; Chen L
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
    J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.
    Hurtado JC; Kim SH; Pollok KE; Lee ZH; Kwon BS
    J Immunol; 1995 Oct; 155(7):3360-7. PubMed ID: 7561030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
    Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
    Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
    Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
    J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
    Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
    Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH
    J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
    DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
    J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-1BB costimulation promotes human T cell adhesion to fibronectin.
    Kim YJ; Mantel PL; June CH; Kim SH; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):13-23. PubMed ID: 10066342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.
    Chu NR; DeBenedette MA; Stiernholm BJ; Barber BH; Watts TH
    J Immunol; 1997 Apr; 158(7):3081-9. PubMed ID: 9120260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
    Hurtado JC; Kim YJ; Kwon BS
    J Immunol; 1997 Mar; 158(6):2600-9. PubMed ID: 9058792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.
    Choi BK; Bae JS; Choi EM; Kang WJ; Sakaguchi S; Vinay DS; Kwon BS
    J Leukoc Biol; 2004 May; 75(5):785-91. PubMed ID: 14694186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses.
    Tan JT; Ha J; Cho HR; Tucker-Burden C; Hendrix RC; Mittler RS; Pearson TC; Larsen CP
    Transplantation; 2000 Jul; 70(1):175-83. PubMed ID: 10919597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
    Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL
    Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
    Habib-Agahi M; Jaberipour M; Searle PF
    Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.